StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

VitaSpring Biomedical's price to sales ratio was 470.9× on Jun 30, 2022, against 463.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jun 30, 2022470.9×+459.9
2021Feb 26, 202111.0×+0.0
2020Dec 31, 202011.0×−452.9
2019Dec 31, 2019463.9×–

More VitaSpring Biomedical figures

See a number that looks wrong?